Cannabis-derived MS treatment filed in Europe
September 5, 2006Sales and Marketing GW Pharmaceuticals, Sativex
Sativex, the cannabis-derived product developed by GW Pharmaceuticals could be finally set for approval after a delay of around two …
Generic Plavix challenge hits BMS and Sanofi forecasts
September 5, 2006Sales and Marketing
A US district court has granted an injunction to stop sales of the generic version of blood-thinner Plavix, the world's …
AstraZeneca and charity spin-off collaborate on colorectal cancer research
September 4, 2006Research and Development
AstraZeneca is to work with a spin-off company set up by Cancer Research UK to research and develop new treatments …
One in four older patients missing out on medicines
September 4, 2006Sales and Marketing patients
More than a quarter of older patients in the UK are missing out on medicines, either because they simply fail …
NICE called on to lead the fight against obesity
September 1, 2006Following grim warnings that more than 12 million adults and one million children in England will be obese in less …
How to make your move
September 1, 2006Business Services career, planning, recruitment
According to a recent survey, four out of every 10 employees are thinking about changing their job in the next …
Contract Sales: the issues in the field
September 1, 2006Sales and Marketing contract sales, outsourcing, sales
The changing NHS customerAs NHS customers change, CSOs are having to adapt and forge new partnerships, and develop new skills.
Women’s European pharma network launched
September 1, 2006Research and Development, Sales and Marketing Europe, association, pharma
Over the years, the numbers of women taking up positions of authority in the pharmaceutical industry has grown considerably, and …
UK pharma suffering an ‘exodus’ of new talent
August 31, 2006Business Services careers, skills
A new survey of the UK pharmaceutical industry suggests the sector is failing to hire the best talent because of …
NICE to fast-track more drugs
August 31, 2006More drugs are to be switched to NICE's new fast-track appraisal system, with the government reaffirming its pledge to end …
EU approval for Novartis’ Exjade
August 31, 2006Sales and Marketing
Novartis' new treatment for the rare and difficult to treat condition of transfusional iron overload has been approved in the …
The right stuff: execs with the Midas touch
August 31, 2006Business Services, Research and Development biotech, management, recruitment
Here's a challenge: find someone with PhD-level scientific knowledge, a strong management track record and entrepreneurial flair. If there are …
GSK signs $1.5 billion drug discovery deal
August 31, 2006Research and Development
GlaxoSmithKline has formed an alliance with Californian biotech company ChemoCentryx through its innovative drug development partnering unit.A licensing deal has …
MabThera shows promise in multiple sclerosis
August 29, 2006Research and Development
The blockbuster non-Hodgkin's lymphoma treatment MabThera could offer a new treatment option for people with multiple sclerosis according to new …
Battle for Herceptin finally over
August 29, 2006Newbury and Community PCT has lost its appeal against NICE's recommendation for cancer drug Herceptin, finally ending the battle over …
Business Intelligence Awards launched
August 23, 2006Sales and Marketing BHBIA
The first ever awards for business intelligence and market research in the UK pharmaceutical industry have been launched to recognise …
Time to get back to our scientific basics
August 23, 2006Research and Development biotech, drug safety, industry reputation
Recently I was wandering through the local market, and found myself in front of a stall selling therapeutic magnets. I …
New broom Kindler sweeps away Pfizer bureaucracy
August 21, 2006Research and Development, Sales and Marketing
Pfizer's new chief executive Jeffery Kindler has unveiled changes to the company's senior management structure just days into his new …
Pfizer switches agencies in time for Sutent’s UK launch
August 18, 2006Medical Communications Reynolds-Mackenzie, Sutent
Pfizer has enlisted PR agency Reynolds-Mackenzie to support the UK launch and subsequent development of its potential blockbuster kidney cancer …
Head-to-head: Nice and the SMC
August 16, 2006Research and Development, Sales and Marketing NICE, SMC, healthcare
The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the Herceptin …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
